Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.3336
-0.0156 (-4.47%)
At close: Nov 16, 2026, 4:00 PM EST
0.3330
-0.0006 (-0.18%)
After-hours: Nov 16, 2026, 7:57 PM EST

Tenaya Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-80.56-93.33-115.95-131.19-125.62-72.81
Net Income
-101.78-90.6-111.13-124.08-123.67-72.72
Earnings Per Share
-0.49-0.59-1.31-1.68-2.76-4.10
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
66.8100.5561.45104.64204.23251.3
Total Debt
2.8510.8313.6112.4215.115.7
Net Cash (Debt)
63.9589.7247.8492.22189.13235.6
Net Cash Growth
42.78%87.54%-48.13%-51.24%-19.72%83.30%
Net Cash Per Share
0.310.590.561.254.2213.29

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-54.41-68.26-90.5-102.07-104.42-60.81
Capital Expenditures
-0.24-0.62-1.03-1.24-20.63-25.12
Free Cash Flow
-54.65-68.88-91.53-103.31-125.05-85.93
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.